Skip to main content
Top
Published in: Clinical Rheumatology 6/2013

01-06-2013 | Case Based Review

Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review

Authors: Soamarat Vilaiyuk, Nongnuch Sirachainan, Suthep Wanitkun, Kwanchai Pirojsakul, Jarin Vaewpanich

Published in: Clinical Rheumatology | Issue 6/2013

Login to get access

Abstract

Macrophage activation syndrome (MAS) is a fatal complication in rheumatic diseases. It is characterized by prolonged fever, pancytopenia, and hepatosplenomegaly, which are consequences of uncontrolled macrophage activation. MAS in children is most commonly associated with systemic juvenile idiopathic arthritis. Its association with systemic lupus erythematosus (SLE) is relatively rare, so we report a Thai boy who initially presented with MAS and eventually was diagnosed as having SLE. He also had recurrent MAS during the course of therapy. Hyperferritinemia is one of the abnormal laboratory findings in MAS and it has been used as an inflammatory marker. However, its correlation with disease activity remains unclear. Therefore, a review of literature regarding MAS-associated SLE in children and ferritin level in this disease was carried out.
Literature
1.
go back to reference Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85(5):421–426PubMedCrossRef Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85(5):421–426PubMedCrossRef
2.
go back to reference Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34(5):1133–1138PubMed Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34(5):1133–1138PubMed
3.
go back to reference Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T et al (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47(11):1686–1691CrossRef Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T et al (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47(11):1686–1691CrossRef
4.
go back to reference Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM (1995) Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 270(25):15285–15293PubMedCrossRef Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM (1995) Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 270(25):15285–15293PubMedCrossRef
5.
go back to reference Bennett TD, Hayward KN, Farris RW, Ringold S, Wallace CA, Brogan TV (2011) Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med 12(6):e233–e236PubMedCrossRef Bennett TD, Hayward KN, Farris RW, Ringold S, Wallace CA, Brogan TV (2011) Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med 12(6):e233–e236PubMedCrossRef
6.
go back to reference Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM (1993) Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11(4):451–456PubMed Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM (1993) Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11(4):451–456PubMed
7.
go back to reference Hadchouel M, Prieur AM, Griscelli C (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 106(4):561–566PubMedCrossRef Hadchouel M, Prieur AM, Griscelli C (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 106(4):561–566PubMedCrossRef
8.
go back to reference Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131PubMedCrossRef Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131PubMedCrossRef
9.
go back to reference Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C et al (2006) Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine(Baltimore) 85(3):169–182 Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C et al (2006) Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine(Baltimore) 85(3):169–182
10.
go back to reference Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S et al (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60(11):3388–3399PubMedCrossRef Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S et al (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60(11):3388–3399PubMedCrossRef
11.
go back to reference Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL (2011) Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 56(1):154–155PubMedCrossRef Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL (2011) Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 56(1):154–155PubMedCrossRef
12.
go back to reference Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T et al (1997) Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 59(4):247–253PubMedCrossRef Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T et al (1997) Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 59(4):247–253PubMedCrossRef
13.
go back to reference Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P et al (2001) Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 68(1):4–10PubMedCrossRef Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P et al (2001) Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 68(1):4–10PubMedCrossRef
14.
go back to reference Campos LM, Omori CH, Lotito AP, Jesus AA, Porta G, Silva CA (2010) Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome? Lupus 19(14):1654–1658PubMedCrossRef Campos LM, Omori CH, Lotito AP, Jesus AA, Porta G, Silva CA (2010) Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome? Lupus 19(14):1654–1658PubMedCrossRef
15.
go back to reference Takizawa Y, Maruyama J, Setoguchi K (2009) Cyclosporin rapidly diminished a severe lupus-associated macrophage activation syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin. Scand J Rheumatol 38(6):492–494PubMedCrossRef Takizawa Y, Maruyama J, Setoguchi K (2009) Cyclosporin rapidly diminished a severe lupus-associated macrophage activation syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin. Scand J Rheumatol 38(6):492–494PubMedCrossRef
16.
go back to reference Yeap ST, Sheen JM, Kuo HC, Hwang KP, Yang KD, Yu HR (2008) Macrophage activation syndrome as initial presentation of systemic lupus erythematosus. Pediatr Neonatol 49(2):39–42PubMedCrossRef Yeap ST, Sheen JM, Kuo HC, Hwang KP, Yang KD, Yu HR (2008) Macrophage activation syndrome as initial presentation of systemic lupus erythematosus. Pediatr Neonatol 49(2):39–42PubMedCrossRef
17.
go back to reference Iagaru N, Oraseanu D, Rusu F, Luminos M, Draganescu A, Ghita A (2010) Macrophage activation syndrome in two girls with systemic lupus erythematosus. Ther Pharmacol Clin Toxicol 15:231–237 Iagaru N, Oraseanu D, Rusu F, Luminos M, Draganescu A, Ghita A (2010) Macrophage activation syndrome in two girls with systemic lupus erythematosus. Ther Pharmacol Clin Toxicol 15:231–237
18.
go back to reference Avcin T, Tse SM, Schneider R, Ngan B, Silverman ED (2006) Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr 148(5):683–686PubMedCrossRef Avcin T, Tse SM, Schneider R, Ngan B, Silverman ED (2006) Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr 148(5):683–686PubMedCrossRef
19.
go back to reference Kwon CM, Jung YW, Yun DY, Kim HD, Cho HS, Hong YH, Choi JH, Lee CK (2008) A case of pericarditis with hemophagocytic syndrome, cytomegalovirus infection and systemic lupus erythematosus. Rheumatol Int 28(3):271–273PubMedCrossRef Kwon CM, Jung YW, Yun DY, Kim HD, Cho HS, Hong YH, Choi JH, Lee CK (2008) A case of pericarditis with hemophagocytic syndrome, cytomegalovirus infection and systemic lupus erythematosus. Rheumatol Int 28(3):271–273PubMedCrossRef
20.
go back to reference Botelho C, Ferrer F, Francisco L, Maia P, Mendes T, Carreira A (2010) Acute lupus hemophagocytic syndrome: report of a case. Nefrologia 30(2):247–251PubMed Botelho C, Ferrer F, Francisco L, Maia P, Mendes T, Carreira A (2010) Acute lupus hemophagocytic syndrome: report of a case. Nefrologia 30(2):247–251PubMed
21.
go back to reference McCann LJ, Hasson N, Pilkington CA (2006) Macrophage activation syndrome as an early presentation of lupus. J Rheumatol 33(2):438–440PubMed McCann LJ, Hasson N, Pilkington CA (2006) Macrophage activation syndrome as an early presentation of lupus. J Rheumatol 33(2):438–440PubMed
22.
go back to reference Kim JM, Kwok SK, Ju JH, Park KS, Park GS, Kim HY, Park SH (2010) Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int 33(3):767–771. doi:10.1007/s00296-010-1654-4 PubMedCrossRef Kim JM, Kwok SK, Ju JH, Park KS, Park GS, Kim HY, Park SH (2010) Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int 33(3):767–771. doi:10.​1007/​s00296-010-1654-4 PubMedCrossRef
23.
go back to reference Ideguchi H, Ohono S, Takase K, Hattori H, Kirino Y, Takeno M et al (2007) Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology 46(10):1621–1622PubMedCrossRef Ideguchi H, Ohono S, Takase K, Hattori H, Kirino Y, Takeno M et al (2007) Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology 46(10):1621–1622PubMedCrossRef
24.
go back to reference You CR, Kim HR, Yoon CH, Lee SH, Park SH, Kim HY (2006) Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report. J Korean Med Sci 21(6):1124–1127PubMedCrossRef You CR, Kim HR, Yoon CH, Lee SH, Park SH, Kim HY (2006) Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report. J Korean Med Sci 21(6):1124–1127PubMedCrossRef
25.
go back to reference Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129(5):750–754PubMedCrossRef Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129(5):750–754PubMedCrossRef
26.
go back to reference Ravelli A, De Benedetti F, Viola S, Martini A (1996) Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 128(2):275–278PubMedCrossRef Ravelli A, De Benedetti F, Viola S, Martini A (1996) Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 128(2):275–278PubMedCrossRef
Metadata
Title
Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review
Authors
Soamarat Vilaiyuk
Nongnuch Sirachainan
Suthep Wanitkun
Kwanchai Pirojsakul
Jarin Vaewpanich
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2227-1

Other articles of this Issue 6/2013

Clinical Rheumatology 6/2013 Go to the issue